Literature DB >> 19737699

First experience with remote left ventricular mapping and transendocardial cell injection with a novel integrated magnetic navigation-guided electromechanical mapping system.

Emerson C Perin1, Guilherme V Silva, Marlos R Fernandes, Torrey Munger, Ashwini Pandey, Ruchir Sehra, Michael Talcott, Christopher J Bichard, Jerett Creed, Jonathan W C Wong, Edie M Oliveira, Yi Zheng, John Canales, Cristiano O Cardoso, Mark S Patterson, Patrick W Serruys.   

Abstract

AIMS: The purpose of this preclinical feasibility study was to evaluate a novel integrated platform in which magnetic navigation is used to remotely guide electromechanical mapping of the left ventricle (LV) and transendocardial cell injections. Using an integrated remote system would greatly facilitate intramyocardial delivery of stem cells for treating ischaemic heart disease. METHODS AND
RESULTS: We used the computer-controlled Stereotaxis magnetic navigation system to guide the NOGA electromechanical mapping system in mapping viable myocardium in the LV of seven pigs. We then tested the feasibility of this system to perform transendocardial injections in three of the pigs and to deliver mesenchymal precursor cells (MPCs) to targeted myocardial segments in four of the pigs. The success or failure of each injection was determined by myocardial contrast staining in the first group and by histopathologic analysis in the last group. The mean time (+/-SD) spent mapping the LV for each pig was 49.3+/-10.6 min. The success rate for transendocardial injections was 94.4%, as indicated by myocardial contrast staining. There was a 95.8% success rate for targeted injections of MPCs, and 4',6-diamidino-2-phenylindole-labeled MPCs were detected in all but one segment of one pig. No epicardial haemorrhage or injury was observed, although there was some venous drainage.
CONCLUSIONS: The integrated Stereotaxis/NOGA system has excellent remote navigability inside the LV cavity while sparing the operator from radiation exposure. This system also allows transendocardial cell injections to be performed with a high success rate. Further studies are needed to define the safety profile of this system for clinical use.

Entities:  

Year:  2007        PMID: 19737699

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  11 in total

Review 1.  Endoventricular electromechanical mapping-the diagnostic and therapeutic utility of the NOGA XP Cardiac Navigation System.

Authors:  Peter J Psaltis; Stephen G Worthley
Journal:  J Cardiovasc Transl Res       Date:  2008-12-10       Impact factor: 4.132

Review 2.  Intramyocardial navigation and mapping for stem cell delivery.

Authors:  Peter J Psaltis; Andrew C W Zannettino; Stan Gronthos; Stephen G Worthley
Journal:  J Cardiovasc Transl Res       Date:  2009-10-23       Impact factor: 4.132

3.  Validation of transcatheter left ventricular electromechanical mapping for assessment of cardiac function and targeted transendocardial injection in a porcine ischemia-reperfusion model.

Authors:  Sharven Taghavi; Jason M Duran; Remus M Berretta; Catherine A Makarewich; Foram Udeshi; Thomas E Sharp; Hajime Kubo; Steven R Houser; Jon C George
Journal:  Am J Transl Res       Date:  2012-04-18       Impact factor: 4.060

Review 4.  Conceptual Design and Procedure for an Autonomous Intramyocardial Injection Catheter.

Authors:  Weyland Cheng; Peter K Law
Journal:  Cell Transplant       Date:  2016-12-07       Impact factor: 4.064

Review 5.  Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective.

Authors:  Peter J Psaltis; Robert D Simari; Martin Rodriguez-Porcel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-08       Impact factor: 9.236

Review 6.  Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease.

Authors:  Mariann Gyöngyösi; Nabil Dib
Journal:  Nat Rev Cardiol       Date:  2011-05-17       Impact factor: 32.419

7.  Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathy.

Authors:  Muzammil Mushtaq; Darcy L DiFede; Samuel Golpanian; Aisha Khan; Samirah A Gomes; Adam Mendizabal; Alan W Heldman; Joshua M Hare
Journal:  J Cardiovasc Transl Res       Date:  2014-10-30       Impact factor: 4.132

8.  Engineered Biomaterials to Enhance Stem Cell-Based Cardiac Tissue Engineering and Therapy.

Authors:  Anwarul Hasan; Renae Waters; Boustany Roula; Rahbani Dana; Seif Yara; Toubia Alexandre; Arghya Paul
Journal:  Macromol Biosci       Date:  2016-03-08       Impact factor: 4.979

Review 9.  Intracoronary delivery of bone-marrow-derived stem cells.

Authors:  Quang T Bui; Zachary M Gertz; Robert L Wilensky
Journal:  Stem Cell Res Ther       Date:  2010-09-23       Impact factor: 6.832

10.  Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model.

Authors:  Emerson C Perin; Mei Tian; Frank C Marini; Guilherme V Silva; Yi Zheng; Fred Baimbridge; Xin Quan; Marlos R Fernandes; Amir Gahremanpour; Daniel Young; Vincenzo Paolillo; Uday Mukhopadhyay; Agatha T Borne; Rajesh Uthamanthil; David Brammer; James Jackson; William K Decker; Amer M Najjar; Michael W Thomas; Andrei Volgin; Brian Rabinovich; Suren Soghomonyan; Hwan-Jeong Jeong; Jesse M Rios; David Steiner; Simon Robinson; Osama Mawlawi; Tinsu Pan; Jason Stafford; Vikas Kundra; Chun Li; Mian M Alauddin; James T Willerson; Elizabeth Shpall; Juri G Gelovani
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.